Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02337634 · ClinicalTrials.gov registry record · Phase 2
Milk Thistle in Pathological Gambling
A Phase 2 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 55
- Enrollment target
NCT02337634 is a Phase 2 study that has completed, run by University of Chicago. The registered enrollment target is 55 participants.
The verdict
NCT02337634, a Phase 2 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 55 participants
- Enrollment target
Study Summary
The goal of the proposed study is to evaluate the efficacy and safety of silymarin in individuals with gambling disorder. The hypothesis to be tested is that silymarin will be more effective and well tolerated in subjects with gambling disorder compared to placebo. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.
Interventions
- DRUG Placebo
- DRUG Milk Thistle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2015-01 |
| Est. Completion | 2022-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02337634
The ClinicalTrials.gov registry entry for NCT02337634 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02337634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02337634 about?
NCT02337634 is a clinical study titled "Milk Thistle in Pathological Gambling". The goal of the proposed study is to evaluate the efficacy and safety of silymarin in individuals with gambling disorder. The hypothesis to be tested is that silymarin will be more effective and well tolerated in subjects with gambling disorder compared to placebo. The proposed study will provide ne...
What is the current status of trial NCT02337634?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 55 participants. The study started on 2015-01. Estimated completion is 2022-12.
What interventions are being tested in trial NCT02337634?
The interventions under investigation include: Placebo (DRUG), Milk Thistle (DRUG).
Who is sponsoring clinical trial NCT02337634?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.